VENU: Sutter Vic discloses securities transactions
By AlphaYouPublished Form 4
Sutter Vic
Reporting filer
Sutter Vic reported Grant or award in Venu Holding Corp: 300000 units of Stock Option (Right to Buy) (derivative), dated 2026-09-23. The full Form 4 contains 1 transaction entry.
- Disclosed
- Sep 25, 2026
Reported details
1 entry| Security | Owner | Date | Code | Action | Quantity | Price | Following holdings | Reporting delay | Filed terms and references |
|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) (derivative) | Sutter Vic | 2026-09-23 | A | Grant or award | 300000 | 0 | 300,000 | 2 days | Filed terms
|
Stock Option (Right to Buy) (derivative)
- Owner
- Sutter Vic
- Date
- 2026-09-23
- Code
- A
- Action
- Grant or award
- Quantity
- 300000
- Price
- 0
- Following holdings
- 300,000
- Reporting delay
- 2 days
- Filed terms and references
Filed terms
- security Title: Stock Option (Right to Buy)
- id: F1
- conversion Or Exercise Price: 2.25
- transaction Date: 2026-09-23
- id: F2
- deemed Execution Date:
- transaction Form Type: 4
- transaction Code: A
- equity Swap Involved: 0
- transaction Timeliness:
- transaction Shares: 300000
- transaction Price Per Share: 0
- transaction Acquired Disposed Code: A
- exercise Date: 2027-07-27
- id: F3
- expiration Date: 2034-07-27
- underlying Security Title: Common Stock
- underlying Security Shares: 300000
- shares Owned Following Transaction: 300000
- direct Or Indirect Ownership: D
Purchases, sales, grants and option exercises are different transactions. The reported code identifies the action; it does not establish a motive.
Filing context
- Quantities and prices are shown in the units filed. No trade value is inferred from their product.
- Sutter Vic: Chief Operating Officer.
- F1: This option was approved by the board of directors (the "Board") of Venu Holding Corporation (the "Issuer") and is exempt from Section 16(b) of the Securities Exchange Act of 1934, as amended, pursuant to Rule 16b-3(d)(1) promulgated thereunder.
- F2: This option grant was approved by the Issuer's Board on July 27, 2026, subject to shareholder approval of an amendment to the Issuer's Amended and Restated 2023 Omnibus Incentive Compensation Plan (the "Plan"), pursuant to which the option was granted, to increase the number of shares of the Issuer's common stock (the "Common Stock") reserved for issuance under the Plan. The Issuer's shareholders approved such amendment to the Plan on September 23, 2026.
- F3: This option vests and becomes exercisable in three equal annual installments of 100,000 shares beginning on July 27, 2027.
Original sources
Prepared automatically from public filing data. Report a correction.